GEA Group Aktiengesellschaft G1A.DE
Composite 57/100; the shares have moved about 25% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 43/100 — a slight mark against it.
Balance-sheet strength ranks 64/100 — a moderate point in its favour. Growth ranks 62/100 — a moderate point in its favour. Income ranks 59/100 — a slight point in its favour.
Valuation ranks 43/100 — a slight mark against it.
What the company does GEA Group supplies process machinery and systems to food, beverage, pharmaceutical, and dairy industries. Its five segments provide separators, pumps, brewing systems, freeze-drying, and digital herd-management tools. The portfolio spans from meat processing to carbon-capture solutions for dairy and new-food applications.
Key financials GEA posts ROE 17%, ROA 6%, and ROCE 18%. Margins include gross 38%, operating 11%, and net 8%. Revenue growth is 1% while EPS grew 7%. Debt/Equity is 0.10 with net cash and interest coverage of 13x. Dividend yield is 2% at a 45% payout.
Stock health Strength pillar is high (75) while growth is low (35). Piotroski F-Score is 7/9 and Altman Z is 3.28. Current ratio is 1.11 and FCF yield is 3%. RSI(14) is 61, with 12-month momentum +5%.
Price vs fair value The stock trades at a PREMIUM of 28.90% versus our fair-value estimate and at a discount of 6.76% versus the analyst 12-month target. - Fair-value premium vs quality-adjusted metrics (Valuation 48, PEG 0.49) (Sideravia) - Discount vs analyst target 67.00 despite low growth (analyst count 17) (data above) - High strength score (75) and strong profitability (ROE 17%, ROCE 18%) (data above) - Low growth score (35) and modest revenue growth (1%) (data above)
Looking forward Forward P/E of 18x implies a 26% discount to trailing P/E of 25x. EV/EBITDA of 10.5x sits below the peer median. Analysts expect upside to 67.00, but growth remains the key watchpoint.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.